Initial Treatment With Lenvatinib Prolongs Survival for Patients With Hepatocellular Carcinoma

Initial treatment with lenvatinib in patients with Barcelona Clinic Liver Cancer stage B2 hepatocellular carcinoma helped prolong survival. Cancer (BCLC) stage B2 hepatocellular carcinoma (HCC) helped prolong survival, according to data from a recent multicenter prospective observational study found that was presented at the 2022 Gastrointestinal Cancers Symposium.1. As...